How is erectile dysfunction treated, and what medications are used?

Erectile dysfunction (ED), commonly referred to as “impotence,” is the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. It affects men of all ages but becomes more prevalent with advancing age, cardiovascular disease, diabetes, obesity, depression, and certain medications. Effective management requires a thorough evaluation—including medical history, physical examination, and, when indicated, laboratory testing (e.g., testosterone, fasting glucose, lipid panel)—to identify underlying causes.

First-line pharmacologic treatment consists of oral phosphodiesterase type 5 (PDE5) inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra). These agents enhance nitric oxide–mediated smooth muscle relaxation in the corpus cavernosum, facilitating blood inflow and erection in response to sexual stimulation. They differ in onset of action (15–60 minutes), duration of effect (4–36 hours), food interactions, and side-effect profiles (e.g., headache, flushing, dyspepsia, visual disturbances with sildenafil/vardenafil, or back pain/muscle aches with tadalafil). Dosing must be individualized and contraindicated in patients using nitrates due to risk of severe hypotension.

Beyond medication, evidence-based nonpharmacologic interventions are essential components of comprehensive care. Lifestyle optimization—including smoking cessation, regular aerobic exercise, weight management, and moderation of alcohol intake—can significantly improve erectile function, particularly in men with metabolic syndrome or early vascular disease. Psychological counseling or sex therapy is strongly recommended when performance anxiety, relationship stress, or depressive symptoms contribute to ED. For select patients, second-line options include intracavernosal injection therapy (e.g., alprostadil), intraurethral alprostadil, vacuum erection devices, or penile prosthesis implantation.

Importantly, ED is often an early marker of systemic vascular disease. Therefore, diagnosis should prompt cardiovascular risk assessment and appropriate preventive strategies—including blood pressure control, statin therapy if indicated, and glycemic management in diabetic patients. Referral to a urologist or sexual medicine specialist is warranted for refractory cases, suspected hormonal abnormalities (e.g., low testosterone confirmed on morning serum testing), or complex comorbidities.